These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27618912)

  • 1. Pathway-specific inhibition of primaquine metabolism by chloroquine/quinine.
    Fasinu PS; Tekwani BL; Avula B; Chaurasiya ND; Nanayakkara NP; Wang YH; Khan IA; Walker LA
    Malar J; 2016 Sep; 15(1):466. PubMed ID: 27618912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential kinetic profiles and metabolism of primaquine enantiomers by human hepatocytes.
    Fasinu PS; Avula B; Tekwani BL; Nanayakkara NP; Wang YH; Bandara Herath HM; McChesney JD; Reichard GA; Marcsisin SR; Elsohly MA; Khan SI; Khan IA; Walker LA
    Malar J; 2016 Apr; 15():224. PubMed ID: 27093859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective metabolism of primaquine by human CYP2D6.
    Fasinu PS; Tekwani BL; Nanayakkara NP; Avula B; Herath HM; Wang YH; Adelli VR; Elsohly MA; Khan SI; Khan IA; Pybus BS; Marcsisin SR; Reichard GA; McChesney JD; Walker LA
    Malar J; 2014 Dec; 13():507. PubMed ID: 25518709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry.
    Avula B; Tekwani BL; Chaurasiya ND; Fasinu P; Dhammika Nanayakkara NP; Bhandara Herath HMT; Wang YH; Bae JY; Khan SI; Elsohly MA; McChesney JD; Zimmerman PA; Khan IA; Walker LA
    Malar J; 2018 Aug; 17(1):294. PubMed ID: 30103751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An LC-MS based study of the metabolic profile of primaquine, an 8-aminoquinoline antiparasitic drug, with an in vitro primary human hepatocyte culture model.
    Jin X; Pybus BS; Marcsisin R; Logan T; Luong TL; Sousa J; Matlock N; Collazo V; Asher C; Carroll D; Olmeda R; Walker LA; Kozar MP; Melendez V
    Eur J Drug Metab Pharmacokinet; 2014 Jun; 39(2):139-46. PubMed ID: 23797843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial.
    St Jean PL; Xue Z; Carter N; Koh GC; Duparc S; Taylor M; Beaumont C; Llanos-Cuentas A; Rueangweerayut R; Krudsood S; Green JA; Rubio JP
    Malar J; 2016 Feb; 15():97. PubMed ID: 26888075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine.
    Daher A; Aljayyoussi G; Pereira D; Lacerda MVG; Alexandre MAA; Nascimento CT; Alves JC; da Fonseca LB; da Silva DMD; Pinto DP; Rodrigues DF; Silvino ACR; de Sousa TN; de Brito CFA; Ter Kuile FO; Lalloo DG
    Malar J; 2019 Sep; 18(1):325. PubMed ID: 31547827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of primaquine to its active metabolite is dependent on CYP 2D6.
    Pybus BS; Marcsisin SR; Jin X; Deye G; Sousa JC; Li Q; Caridha D; Zeng Q; Reichard GA; Ockenhouse C; Bennett J; Walker LA; Ohrt C; Melendez V
    Malar J; 2013 Jun; 12():212. PubMed ID: 23782898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The conversion of primaquine into primaquine-aldehyde, primaquine-alcohol, and carboxyprimaquine, a major plasma metabolite.
    Frischer H; Mellovitz RL; Ahmad T; Nora MV
    J Lab Clin Med; 1991 Jun; 117(6):468-76. PubMed ID: 2045714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-clinical evaluation of CYP 2D6 dependent drug-drug interactions between primaquine and SSRI/SNRI antidepressants.
    Jin X; Potter B; Luong TL; Nelson J; Vuong C; Potter C; Xie L; Zhang J; Zhang P; Sousa J; Li Q; Pybus BS; Kreishman-Deitrick M; Hickman M; Smith PL; Paris R; Reichard G; Marcsisin SR
    Malar J; 2016 May; 15(1):280. PubMed ID: 27188854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantioselective pharmacokinetics of primaquine in healthy human volunteers.
    Tekwani BL; Avula B; Sahu R; Chaurasiya ND; Khan SI; Jain S; Fasinu PS; Herath HM; Stanford D; Nanayakkara NP; McChesney JD; Yates TW; ElSohly MA; Khan IA; Walker LA
    Drug Metab Dispos; 2015 Apr; 43(4):571-7. PubMed ID: 25637634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling primaquine metabolites in primary human hepatocytes using UHPLC-QTOF-MS with 13C stable isotope labeling.
    Avula B; Tekwani BL; Chaurasiya ND; Nanayakkara NP; Wang YH; Khan SI; Adelli VR; Sahu R; Elsohly MA; McChesney JD; Khan IA; Walker LA
    J Mass Spectrom; 2013 Feb; 48(2):276-85. PubMed ID: 23378100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population.
    Spring MD; Sousa JC; Li Q; Darko CA; Morrison MN; Marcsisin SR; Mills KT; Potter BM; Paolino KM; Twomey PS; Moon JE; Tosh DM; Cicatelli SB; Froude JW; Pybus BS; Oliver TG; McCarthy WF; Waters NC; Smith PL; Reichard GA; Bennett JW
    J Infect Dis; 2019 Oct; 220(11):1761-1770. PubMed ID: 31549155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: Current state of the art.
    Marcsisin SR; Reichard G; Pybus BS
    Pharmacol Ther; 2016 May; 161():1-10. PubMed ID: 27016470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarials inhibit human erythrocyte membrane acetylcholinesterase.
    Katewa SD; Katyare SS
    Drug Chem Toxicol; 2005; 28(4):467-82. PubMed ID: 16298876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine.
    Pybus BS; Sousa JC; Jin X; Ferguson JA; Christian RE; Barnhart R; Vuong C; Sciotti RJ; Reichard GA; Kozar MP; Walker LA; Ohrt C; Melendez V
    Malar J; 2012 Aug; 11():259. PubMed ID: 22856549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative single dose pharmacokinetics and metabolism of racemic primaquine and its enantiomers in human volunteers.
    Khan W; Wang YH; Chaurasiya ND; Nanayakkara ND; Herath HB; Harrison KA; Dale G; Stanford DA; Dahl EP; McChesney JD; Gul W; ElSohly MA; Khan SI; Fasinu PS; Khan IA; Tekwani BL; Walker LA
    Drug Metab Pharmacokinet; 2022 Aug; 45():100463. PubMed ID: 35709685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta).
    Saunders D; Vanachayangkul P; Imerbsin R; Khemawoot P; Siripokasupkul R; Tekwani BL; Sampath A; Nanayakkara NP; Ohrt C; Lanteri C; Gettyacamin M; Teja-Isavadharm P; Walker L
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7283-91. PubMed ID: 25267666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses.
    Silvino AC; Costa GL; Araújo FC; Ascher DB; Pires DE; Fontes CJ; Carvalho LH; Brito CF; Sousa TN
    PLoS One; 2016; 11(7):e0160172. PubMed ID: 27467145
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Pett H; Bradley J; Okebe J; Dicko A; Tiono AB; Gonçalves BP; Stone W; Chen I; Lanke K; Neuvonen M; Mustaniemi AL; Eziefula AC; Gosling R; D'Alessandro U; Drakeley C; Niemi M; Bousema T
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.